MedPage Today December 3, 2024
— Companies promising to speed up drug discovery by using machine learning to analyze huge datasets
Artificial intelligence (AI) is changing the way companies do business — helping programmers write code and fielding customer service calls with chatbots.
But the pharmaceutical industry is still waiting to see whether AI can tackle its biggest challenge: finding faster, cheaper ways to develop new drugs.
Despite billions poured into research, new medicines still typically take a decade or more to develop.
Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical and biological markers. The South San Francisco-based company has signed deals with drugmakers like...
Today's Sponsors
Today's Sponsor